Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2019. Start Trial.
Date Value
October 23, 2026 0.0705
October 22, 2026 0.0735
October 21, 2026 0.0647
October 20, 2026 0.0632
October 19, 2026 0.0605
October 16, 2026 0.0605
October 15, 2026 0.0674
October 14, 2026 0.0645
October 13, 2026 0.0704
October 12, 2026 0.0757
October 09, 2026 0.0771
October 08, 2026 0.0789
October 07, 2026 0.0837
October 06, 2026 0.084
October 05, 2026 0.1109
October 02, 2026 0.0974
October 01, 2026 0.1041
September 30, 2026 0.1085
September 29, 2026 0.1174
September 28, 2026 0.1286
September 25, 2026 0.1429
September 24, 2026 0.1429
September 23, 2026 0.1488
September 22, 2026 0.1808
September 21, 2026 0.1952
Date Value
September 18, 2026 0.191
September 17, 2026 0.1843
September 16, 2026 0.1948
September 15, 2026 0.2617
September 14, 2026 0.2895
September 11, 2026 0.3437
September 10, 2026 0.5006
September 09, 2026 0.4384
September 08, 2026 0.4194
September 04, 2026 0.3997
September 03, 2026 0.3845
September 02, 2026 0.3856
September 01, 2026 0.387
August 31, 2026 0.371
August 28, 2026 0.3745
August 27, 2026 0.3577
August 26, 2026 0.3545
August 25, 2026 0.3653
August 24, 2026 0.3629
August 21, 2026 0.3721
August 20, 2026 0.378
August 19, 2026 0.3699
August 18, 2026 0.368
August 17, 2026 0.391
August 14, 2026 0.3978

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 20.32
Anika Therapeutics, Inc. 2.088
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.376

Price to Book Value Related Metrics

PS Ratio 0.3171
PEG Ratio -0.0001
Price 0.2605
Earnings Yield -83.16K%
Market Cap 0.328M
PEGY Ratio -0.0001